Mitochondrial aldehyde dehydrogenase 2 (ALDH2) is critical in the pathogenesis of alcoholic liver cirrhosis. However, the effect of ALHD2 on liver fibrosis remains to be further elucidated. This study aimed to demonstrate whether ALDH2 regulates carbon tetrachloride (CCl 4 )-induced liver fibrosis and to investigate the efficacy of Alda-1, a specific activator of ALDH2, on attenuating liver fibrosis. ALDH2 expression was increased after chronic CCl 4 exposure. ALDH2 deficiency accentuated --
| INTRODUCTION
Liver fibrosis is a consequence of wound-healing process responded to several types of acute or chronic liver injury, including ethanol consumption, viral infection, fatty liver disease and metabolic disorders. [1] [2] [3] Although early-phase liver fibrosis is considered a reversible pathological process, late-stage liver fibrosis will deteriorate to cirrhosis, portal hypertension or even hepatocellular carcinoma, which lead to increased morbidity and mortality. 4, 5 Carbon tetrachloride (CCl 4 ) is a widely used toxicant in experimental animals to induce liver lesion and liver fibrosis. 6 Chronic CCl 4 exposure causes collagen deposition, hepatocellular damage, oxidative stress and activation of hepatic stellate cells (HSCs). 7 Activated HSCs promote syntheses of extracellular matrix proteins and expression of tissue inhibitor of metalloproteinase (TIMP), increase cell migration and proliferation, and enhance the fibrogenic capacity. 8, 9 Oxidative stress and reactive oxygen species (ROS) generated during toxicant metabolism was proved to be involved in the activation of HSCs and the progression of liver fibrosis. 10, 11 Several antioxidant systems are involved in the protection against oxidative stress under physiological and pathological conditions. Nuclear factor erythroid 1-related factor 2 (Nrf2) is a nuclear transcription factor which binds to antioxidant response element (ARE) and participates in regulating transcription and expression of antioxidant enzymes. 12 Previous study has proved that activation of Nrf2 could alleviate the progression of liver fibrosis. 13, 14 Heme oxygenase-1 (HO-1) is an antioxidant enzyme which is commonly up-regulated upon the stimulation of oxidative stress and injury. 15 Notably, Nrf2 can directly regulate the expression of HO-1, [16] [17] [18] which shed light on the role of Nrf2/HO-1 pathway in protecting against further hepatic damage. 16 In addition, autophagy/mitophagy could serve as a cellular protective mechanism in attenuating ROS overproduction and mitochondrial damage in several liver diseases. 19, 20 Therefore, inhibition of ROS generation could provide a potential therapeutic target for attenuating hepatic fibrosis.
Aldehyde dehydrogenase 2 (ALDH2) is a key enzyme that metabolizes reactive acetaldehyde into non-toxic acetic acid, and detoxifies ROS-generated aldehyde substances such as 4-hydroxy-2-nonenal (4-HNE) and malondialdehyde (MDA). 21, 22 Nearly, half of the EastAsian population possessed the genetic mutation which results in the deficiency of ALDH2 activity. 23, 24 Findings from our laboratory and others revealed a beneficial role of ALDH2 in rescuing against certain diseases, such as ischemia heart disease, alcoholic liver disease and stroke, 25, 26 which might be mediated through regulating oxidation stress, apoptosis and autophagy. [27] [28] [29] [30] [31] Nevertheless, the role of ALDH2 in CCl 4 -induced chronic liver fibrosis and the underlying mechanisms remains to be further elucidated. To this end, the present study was designed to investigate the effects of ALDH2 on CCl 4 -induced liver fibrosis, collagen deposition and oxidative stress.
Furthermore, Alda-1, a specific ALDH2 activator, was administered to further demonstrate the therapeutic effect of ALDH2 activation on liver fibrosis.
| MATERIALS AND METHODS

| Animals and groups
Adult male C57BL/6 (8-week old) was purchased from Shanghai Animal Administration Centre (Shanghai, China) and ALDH2 knockout mice with the same genetic background were reproduced as described previously. 32 
| Samples and parameters
Mice were submitted an 8-week CCl 4 exposure and killed under deep anaesthesia with sodium pentobarbital (150 mg/kg, i.p.). The serum was collected by centrifugation for biochemical analysis. ALT and AST were determined with biochemical kits which were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Livers were photographed and weighted to calculate liver/ body ratio. 
| Histopathological and immunohistochemical analyses
| Western blot analyses
Samples containing equal amounts of proteins were separated by 
| Statistical analyses
The data are presented as the means AE standard error of mean (SEM) and compared with Student's independent t test to analyse 2 groups. One-way ANOVA was performed to analyse multiple groups, followed by LSD analysis. The survival curve was made with
GraphPad Prism 5 and the other data were analysed with SPSS software (version 18.0). Values of P < .05 were considered statistically significant.
| RESULTS
| ALDH2 deficiency deteriorates CCl 4 -induced liver function
The 
| ALDH2 deficiency accentuates hepatic fibrosis and collagen deposition
To examine the effect of ALDH2 deficiency on CCl 4 
| ALDH2 deficiency cause more ROS production in response to CCl 4 administration
Since hepatic oxidative stress is involved in the development of liver fibrosis, we measured CCl 4 -induced ROS production using DHE staining among the 4 groups. As shown in Figure 3A ,B, barely no positive DHE staining could be found in the liver of oil-treated mice;
however, much more positive DHE staining was found after The values represent means AE SEM (n = 7-9). *P < .05, **P < .01, ***P < .001. Scare bar, 100 lm production in the liver, which might be partly through downregulating the antioxidant signalling. As shown in Figure 4 , the protein expression of Parkin was significantly decreased after CCl 4 treatment, which was further decreased in ALDH2 À/À mice. Taken together, these data suggested that CCl 4 administration promotes hepatic apoptosis and deteriorates autophagy/mitophagy, leading to impaired hepatic function, while ALDH2 deficiency further accentuates the deteriorative effect of CCl 4 .
| ALDH2 activation by Alda-1 blocks TGF-b1-induced HSC-T6 cell activation through attenuating ROS generation
Previous study showed that TGF-b1 could up-regulate the expression of collagen gene via ROS overproduction, this process eventually triggered HSCs activation and liver fibrogenesis. 33 Firstly, we examined the relative mRNA expression level of ALDH2 in both 
| DISCUSSION
The salient findings of this study revealed that global ALDH2 deficiency aggravated liver injury and liver fibrosis induced by chronic The values represent means AE SEM (n = 6-9). *P < .05, **P < .01, ***P < .001. Scare bar, 100 lm. C, Representative western blot pictures of p62, LC3 and Parkin. D, Quantification analyses of the expression of p62, LC3 and Parkin. The values represent means AE SEM (n = 6-9). *P < .05, **P < .01, ***P < .001. Scare bar, 100 lm as 4-HNE and MDA. 21, 22 Several studies have revealed the protective role of ALDH2 in alcoholic liver cirrhosis and liver cancer. 36, 37 Given that nearly half of the East Asian population possessed the loss-of-function mutation of ALDH2, the role of ALDH2 in liver fibrosis still needs further elucidation. In the present study, chronic The protective role of ALDH2 prompted us to determine whether ALDH2 activation could ameliorate CCl 4 -induced liver fibrosis in vivo.
As a special activator of ALDH2, Alda-1 was firstly discovered by Chen et al 42 in 2008 and was proved to play a beneficial role in attenuating ischemia-induced heart dysfunction. Our results revealed that Alda-1 could significantly decrease TGF-b1-induced ROS production in vitro and alleviate CCl 4 -induced liver fibrosis in vivo.
Mitochondrion is the main producer of ROS, which will in turn target mitochondria and cause mitochondrial damage. 43 Studies have proved the critical role of mitochondrial homeostasis in maintaining hepatic function in the progression of liver diseases. 44, 45 Autophagy is a metabolic process which involves in sensing oxidative stress and removing oxidatively damaged cytoplasmic organelles or cytosolic components. 46 In particular, mitophagy appears to be critical in removing impaired mitochondria, thereby preventing ROS overproduction and cell damage. 47 Mitophagy is activated by mitochondrial membrane depolarization, which induces the stabilization of PINK1 on the mitochondrial outer membrane and recruiting of Parkin from the cytosol. This initiates the localization of damaged mitochondria to membranes containing LC3, leading to the formation of autophagosomes, followed by fusion with lysosomes and clearance from cells. 48 A previous study reported that mitophagy is impaired in the liver exposed to chronic CCl 4 , as evidenced by increased p62 expression and LC3-II/LC3-I ratio and decreased PINK1 and Parkin protein expression. 49 Consistently, we observed increased expression of p62 and LC3-II/LC3-I ratio and decreased Parkin expression in the liver after chronic CCl 4 treatment, which were further aggravated by ALDH2 deficiency, whereas ALDH2 activation by Alda-1 significantly reversed the effect of CCl 4 .
Nrf2 is an important oxidative stress regulator which modulates HO-1, GST, GCLC and GCLM. 50, 51 Several studies have highlighted the beneficial role of antioxidants to protect against liver damage through activating the Nrf2/HO-1 defence pathway. 52, 53 In the pre- 
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